Ana Blasco

Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Juan Virizuela Echaburu et al. · Journal of Clinical Oncology · 2015 · 161 citations · Full text

Medicine, Oncology, Cancer Epidemiology +12

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial

Carlos Camps, Bartomeu Massutí, Ángel Martín Jiménez et al. · Annals of Oncology · 2005 · 130 citations

Medicine, Oncology, Pharmacotherapy +11

Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer

Leonor Puchades‐Carrasco, Eloísa Jantus‐Lewintre, Clara Pérez-Rambla et al. · Oncotarget · 2016 · 106 citations · Full text

Medicine, Biochemistry, Oncology +17

Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)

Ernest Nadal, Delvys Rodríguez‐Abreu, Marta Simó et al. · Journal of Clinical Oncology · 2023 · 106 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer

Alejandro Herreros‐Pomares, Juan Diego de-Maya-Girones, Silvia Calabuig‐Fariñas et al. · Cell Death and Disease · 2019 · 105 citations · Full text

Medicine, Cell Biology, Oncology +17